Ori Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform
Funds will allow for a rapid transition through pre-commercialization to market launch.
Medtech startup Charco's seed round, led by Amadeus Capital Partners and Parkwalk Advisors, will support the launch of CUE1, a novel therapy with a waiting list of more than 5000 people. It is the largest European seed financing and sixth largest globally in 2021 for healthtech devices. Charco collaborates with the European Parkinson’s Disease Association to help provide the latest solutions to…
Amadeus Capital Partners has announced that it has expanded its deep tech investment team with the appointment of Dr Manjari Chandran-Ramesh as a Partner in its Early Stage Team. Manjari will focus on investing in start-ups and spinouts centring on machine learning and quantum technologies, in the Oxford innovation cluster and other university centres throughout the UK.
Amadeus CEO Anne Glover has won the prestigious award Hall of Fame Award at GP Bullhound’s Investor Allstars event.
Oxford Nanopore’s successful IPO is inspiring news for biotech entrepreneurs and a testament to the extraordinary vision of its founder and CEO Gordon Sanghera.
Altana AI raises $15m Series A investment to build the single source of truth on the global supply chain
Altana AI has secured $15 million in Series A funding, led by GV (formerly Google Ventures). Floating Point, Ridgeline Partners. Existing investors Amadeus Capital Partners and Schematic Ventures joined the round, which closed in May 2021.
PolyAI raises $14m from Khosla Ventures to accelerate US expansion for ‘superhuman’ voice assistants
Enterprise voice bot market heats up as companies use AI to route calls, answer questions, book reservations and take orders.
Amadeus Capital Partners, the global technology investor, reinforces commitment to Latin America by hiring a new partner in São Paulo, Beatriz Amary.
Transformational Augmented Reality (AR) platform sets a new standard in construction. Uses holograms to deliver megaprojects across Europe.
Cryptosense, a cryptography lifecycle management platform, has announced a $4.8 million funding round led by Amadeus Capital Partners with participation from BGV and Elaia Partners.
Sprout.ai, the company that uses AI to enable insurance claims to be settled within just 24 hours, announced that it has raised £8m ($11m) in Series A funding.
Global technology investor Amadeus Capital Partners has announced the closing at £110 million of its latest early stage, deep tech investment platform, the Amadeus V Technology Fund, which includes a cornerstone commitment by British Patient Capital, the UK’s largest investor in venture and venture growth opportunities.
Doctify, a healthcare review platform, has announced an additional $7.5M in its latest funding round, taking the overall investment to $20M.
CDC Group appoints CEO of Amadeus Capital as new Investment Committee member as it expands its venture capital programme
CDC Group (CDC), the UK’s publicly owned impact investor, has appointed two of the best-known names in the venture capital industry as investment committee members, as it prepares to expand its interests in the sector.
University of Cambridge spin-out Xampla has announced it has closed a £6.2m seed finance round, led by the backers of Zoom, to accelerate the roll-out of its next-generation plastic replacement. The investment follows a £2m round announced in April.
Graphcore – maker of the Intelligence Processing Unit which is a new type of microprocessor specifically designed to support artificial intelligence workloads – announced that it has raised $222 million in a Series E funding round that values the company at $2.77 billion post-money.
V7 Labs, the computer vision platform trusted by hundreds of customers including Tractable, GE Healthcare and Merck, has announced the closing of a $3M Seed round led by Amadeus Capital Partners, joined by Partech, Air Street Capital, and Miele Venture.
New York, NY – Altana AI, a start-up working with governments, global enterprises, and supply chain solutions providers to de-risk global supply chains, announced a seed investment of $7 million. The funding round was led by Amadeus Capital Partners, a London-based venture capital firm with a long track record of backing artificial intelligence, risk management, and national security technology…
Pimloc, the visual privacy and security company, has closed £1.4m in new financing in a seed funding round led by Amadeus Capital Partners with participation from Speedinvest and existing shareholders.
Veritas Intercontinental closes €5 million of new financing to expand its leadership in preventive genomics
Veritas Intercontinental, a leader in the application of preventive genomic medicine, has completed a new financing of €5 million that strengthens its international expansion and the development of new operational and technological capabilities.
Ori Biotech Raises $30m in Series A financing to advance innovation in cell and gene therapy manufacturing
October 14 2020, London, UK and Woodcliff Lake, NJ – Ori Biotech Ltd (Ori), a leading innovator in cell and gene therapy (CGT) manufacturing, today announced the successful close of a $30 million Series A financing round, bringing the company’s total funding to date to $41 million.
Nu Quantum raises £2.1m Seed investment to accelerate the commercialisation of pioneering quantum photonics hardware
Nu Quantum, the quantum photonics company, has raised £2.1 million in Seed funding in a round led by Amadeus Capital Partners.
Runa Capital, Amadeus Capital Partners and two individual investors have acquired 100% of shares in fintech, Kontomatik. The investment will allow Kontomatik to implement the company’s business strategy independently and market its open banking-based services across Europe.
London and Bogotá – Global technology investor, Amadeus Capital Partners, today announces a major expansion of its investment team. Edward Kliphuis and Kai Schmitz have joined as Partners and Ana Bernardo-Gancedo as a Healthcare Analyst.
Boston, USA...Lumeon, the leader in care pathway orchestration, announced that it has closed $30M in Series D funding led by new investors Optum Ventures and Endeavour Vision, with participation from current investors LSP, MTIP, IPF Partners, Gilde and Amadeus Capital Partners.